English
简体中文
Total: £ 56.28
Published Date: 2024-11-19 | Pages: 127 | Tables: 230 | Pharma & Healthcare
The global market for Paclitaxel and Docetaxel was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Paclitaxel and Docetaxel was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Paclitaxel and Docetaxel was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Paclitaxel and Docetaxel was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Paclitaxel and Docetaxel include Phyton, ScinoPharm, Novasep, Samyang, Polymed, TAPI (Teva), Fresenius-kabi, Huiang biopharma and Southpharma, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Paclitaxel and Docetaxel, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Paclitaxel and Docetaxel by region & country, by Type, and by Application.
The Paclitaxel and Docetaxel market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paclitaxel and Docetaxel.
Market Segmentation
By Company
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
Segment by Type:
Paclitaxel
Docetaxel
Segment by Application
Ovarian Cancer
Cervical Cancer
Breast Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Paclitaxel and Docetaxel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Paclitaxel and Docetaxel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Paclitaxel and Docetaxel in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Paclitaxel and Docetaxel Product Introduction
1.2 Global Paclitaxel and Docetaxel Market Size Forecast
1.2.1 Global Paclitaxel and Docetaxel Sales Value (2019-2030)
1.2.2 Global Paclitaxel and Docetaxel Sales Volume (2019-2030)
1.2.3 Global Paclitaxel and Docetaxel Sales Price (2019-2030)
1.3 Paclitaxel and Docetaxel Market Trends & Drivers
1.3.1 Paclitaxel and Docetaxel Industry Trends
1.3.2 Paclitaxel and Docetaxel Market Drivers & Opportunity
1.3.3 Paclitaxel and Docetaxel Market Challenges
1.3.4 Paclitaxel and Docetaxel Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Paclitaxel and Docetaxel Players Revenue Ranking (2023)
2.2 Global Paclitaxel and Docetaxel Revenue by Company (2019-2024)
2.3 Global Paclitaxel and Docetaxel Players Sales Volume Ranking (2023)
2.4 Global Paclitaxel and Docetaxel Sales Volume by Company Players (2019-2024)
2.5 Global Paclitaxel and Docetaxel Average Price by Company (2019-2024)
2.6 Key Manufacturers Paclitaxel and Docetaxel Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Paclitaxel and Docetaxel Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Paclitaxel and Docetaxel
2.9 Paclitaxel and Docetaxel Market Competitive Analysis
2.9.1 Paclitaxel and Docetaxel Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Paclitaxel and Docetaxel Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paclitaxel and Docetaxel as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Paclitaxel
3.1.2 Docetaxel
3.2 Global Paclitaxel and Docetaxel Sales Value by Type
3.2.1 Global Paclitaxel and Docetaxel Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Paclitaxel and Docetaxel Sales Value, by Type (2019-2030)
3.2.3 Global Paclitaxel and Docetaxel Sales Value, by Type (%) (2019-2030)
3.3 Global Paclitaxel and Docetaxel Sales Volume by Type
3.3.1 Global Paclitaxel and Docetaxel Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Paclitaxel and Docetaxel Sales Volume, by Type (2019-2030)
3.3.3 Global Paclitaxel and Docetaxel Sales Volume, by Type (%) (2019-2030)
3.4 Global Paclitaxel and Docetaxel Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Ovarian Cancer
4.1.2 Cervical Cancer
4.1.3 Breast Cancer
4.1.4 Others
4.2 Global Paclitaxel and Docetaxel Sales Value by Application
4.2.1 Global Paclitaxel and Docetaxel Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Paclitaxel and Docetaxel Sales Value, by Application (2019-2030)
4.2.3 Global Paclitaxel and Docetaxel Sales Value, by Application (%) (2019-2030)
4.3 Global Paclitaxel and Docetaxel Sales Volume by Application
4.3.1 Global Paclitaxel and Docetaxel Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Paclitaxel and Docetaxel Sales Volume, by Application (2019-2030)
4.3.3 Global Paclitaxel and Docetaxel Sales Volume, by Application (%) (2019-2030)
4.4 Global Paclitaxel and Docetaxel Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Paclitaxel and Docetaxel Sales Value by Region
5.1.1 Global Paclitaxel and Docetaxel Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Paclitaxel and Docetaxel Sales Value by Region (2019-2024)
5.1.3 Global Paclitaxel and Docetaxel Sales Value by Region (2025-2030)
5.1.4 Global Paclitaxel and Docetaxel Sales Value by Region (%), (2019-2030)
5.2 Global Paclitaxel and Docetaxel Sales Volume by Region
5.2.1 Global Paclitaxel and Docetaxel Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Paclitaxel and Docetaxel Sales Volume by Region (2019-2024)
5.2.3 Global Paclitaxel and Docetaxel Sales Volume by Region (2025-2030)
5.2.4 Global Paclitaxel and Docetaxel Sales Volume by Region (%), (2019-2030)
5.3 Global Paclitaxel and Docetaxel Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Paclitaxel and Docetaxel Sales Value, 2019-2030
5.4.2 North America Paclitaxel and Docetaxel Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Paclitaxel and Docetaxel Sales Value, 2019-2030
5.5.2 Europe Paclitaxel and Docetaxel Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Paclitaxel and Docetaxel Sales Value, 2019-2030
5.6.2 Asia Pacific Paclitaxel and Docetaxel Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Paclitaxel and Docetaxel Sales Value, 2019-2030
5.7.2 South America Paclitaxel and Docetaxel Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Paclitaxel and Docetaxel Sales Value, 2019-2030
5.8.2 Middle East & Africa Paclitaxel and Docetaxel Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Paclitaxel and Docetaxel Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Paclitaxel and Docetaxel Sales Value
6.2.1 Key Countries/Regions Paclitaxel and Docetaxel Sales Value, 2019-2030
6.2.2 Key Countries/Regions Paclitaxel and Docetaxel Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Paclitaxel and Docetaxel Sales Value, 2019-2030
6.3.2 United States Paclitaxel and Docetaxel Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Paclitaxel and Docetaxel Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Paclitaxel and Docetaxel Sales Value, 2019-2030
6.4.2 Europe Paclitaxel and Docetaxel Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Paclitaxel and Docetaxel Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Paclitaxel and Docetaxel Sales Value, 2019-2030
6.5.2 China Paclitaxel and Docetaxel Sales Value by Type (%), 2023 VS 2030
6.5.3 China Paclitaxel and Docetaxel Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Paclitaxel and Docetaxel Sales Value, 2019-2030
6.6.2 Japan Paclitaxel and Docetaxel Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Paclitaxel and Docetaxel Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Paclitaxel and Docetaxel Sales Value, 2019-2030
6.7.2 South Korea Paclitaxel and Docetaxel Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Paclitaxel and Docetaxel Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Paclitaxel and Docetaxel Sales Value, 2019-2030
6.8.2 Southeast Asia Paclitaxel and Docetaxel Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Paclitaxel and Docetaxel Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Paclitaxel and Docetaxel Sales Value, 2019-2030
6.9.2 India Paclitaxel and Docetaxel Sales Value by Type (%), 2023 VS 2030
6.9.3 India Paclitaxel and Docetaxel Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Phyton
7.1.1 Phyton Company Information
7.1.2 Phyton Introduction and Business Overview
7.1.3 Phyton Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Phyton Paclitaxel and Docetaxel Product Offerings
7.1.5 Phyton Recent Development
7.2 ScinoPharm
7.2.1 ScinoPharm Company Information
7.2.2 ScinoPharm Introduction and Business Overview
7.2.3 ScinoPharm Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2019-2024)
7.2.4 ScinoPharm Paclitaxel and Docetaxel Product Offerings
7.2.5 ScinoPharm Recent Development
7.3 Novasep
7.3.1 Novasep Company Information
7.3.2 Novasep Introduction and Business Overview
7.3.3 Novasep Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Novasep Paclitaxel and Docetaxel Product Offerings
7.3.5 Novasep Recent Development
7.4 Samyang
7.4.1 Samyang Company Information
7.4.2 Samyang Introduction and Business Overview
7.4.3 Samyang Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Samyang Paclitaxel and Docetaxel Product Offerings
7.4.5 Samyang Recent Development
7.5 Polymed
7.5.1 Polymed Company Information
7.5.2 Polymed Introduction and Business Overview
7.5.3 Polymed Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Polymed Paclitaxel and Docetaxel Product Offerings
7.5.5 Polymed Recent Development
7.6 TAPI (Teva)
7.6.1 TAPI (Teva) Company Information
7.6.2 TAPI (Teva) Introduction and Business Overview
7.6.3 TAPI (Teva) Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2019-2024)
7.6.4 TAPI (Teva) Paclitaxel and Docetaxel Product Offerings
7.6.5 TAPI (Teva) Recent Development
7.7 Fresenius-kabi
7.7.1 Fresenius-kabi Company Information
7.7.2 Fresenius-kabi Introduction and Business Overview
7.7.3 Fresenius-kabi Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Fresenius-kabi Paclitaxel and Docetaxel Product Offerings
7.7.5 Fresenius-kabi Recent Development
7.8 Huiang biopharma
7.8.1 Huiang biopharma Company Information
7.8.2 Huiang biopharma Introduction and Business Overview
7.8.3 Huiang biopharma Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Huiang biopharma Paclitaxel and Docetaxel Product Offerings
7.8.5 Huiang biopharma Recent Development
7.9 Southpharma
7.9.1 Southpharma Company Information
7.9.2 Southpharma Introduction and Business Overview
7.9.3 Southpharma Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Southpharma Paclitaxel and Docetaxel Product Offerings
7.9.5 Southpharma Recent Development
7.10 Yunnan Hande
7.10.1 Yunnan Hande Company Information
7.10.2 Yunnan Hande Introduction and Business Overview
7.10.3 Yunnan Hande Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Yunnan Hande Paclitaxel and Docetaxel Product Offerings
7.10.5 Yunnan Hande Recent Development
7.11 Hainan Yew Pharm
7.11.1 Hainan Yew Pharm Company Information
7.11.2 Hainan Yew Pharm Introduction and Business Overview
7.11.3 Hainan Yew Pharm Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Hainan Yew Pharm Paclitaxel and Docetaxel Product Offerings
7.11.5 Hainan Yew Pharm Recent Development
7.12 Jiangsu Yew Biotechnology
7.12.1 Jiangsu Yew Biotechnology Company Information
7.12.2 Jiangsu Yew Biotechnology Introduction and Business Overview
7.12.3 Jiangsu Yew Biotechnology Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Jiangsu Yew Biotechnology Paclitaxel and Docetaxel Product Offerings
7.12.5 Jiangsu Yew Biotechnology Recent Development
8 Industry Chain Analysis
8.1 Paclitaxel and Docetaxel Industrial Chain
8.2 Paclitaxel and Docetaxel Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Paclitaxel and Docetaxel Sales Model
8.5.2 Sales Channel
8.5.3 Paclitaxel and Docetaxel Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Paclitaxel and Docetaxel Market Trends
Table 2. Paclitaxel and Docetaxel Market Drivers & Opportunity
Table 3. Paclitaxel and Docetaxel Market Challenges
Table 4. Paclitaxel and Docetaxel Market Restraints
Table 5. Global Paclitaxel and Docetaxel Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Paclitaxel and Docetaxel Revenue Market Share by Company (2019-2024)
Table 7. Global Paclitaxel and Docetaxel Sales Volume by Company (2019-2024) & (Kiloton)
Table 8. Global Paclitaxel and Docetaxel Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Paclitaxel and Docetaxel Price by Company (2019-2024) & (US$/Ton)
Table 10. Key Manufacturers Paclitaxel and Docetaxel Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Paclitaxel and Docetaxel Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Paclitaxel and Docetaxel
Table 13. Global Paclitaxel and Docetaxel Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paclitaxel and Docetaxel as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Paclitaxel and Docetaxel Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Paclitaxel and Docetaxel Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Paclitaxel and Docetaxel Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Paclitaxel and Docetaxel Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Paclitaxel and Docetaxel Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Paclitaxel and Docetaxel Sales Volume by Type: 2019 VS 2023 VS 2030 (Kiloton)
Table 22. Global Paclitaxel and Docetaxel Sales Volume by Type (2019-2024) & (Kiloton)
Table 23. Global Paclitaxel and Docetaxel Sales Volume by Type (2025-2030) & (Kiloton)
Table 24. Global Paclitaxel and Docetaxel Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Paclitaxel and Docetaxel Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Paclitaxel and Docetaxel Price by Type (2019-2024) & (US$/Ton)
Table 27. Global Paclitaxel and Docetaxel Price by Type (2025-2030) & (US$/Ton)
Table 28. Global Paclitaxel and Docetaxel Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Paclitaxel and Docetaxel Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Paclitaxel and Docetaxel Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Paclitaxel and Docetaxel Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Paclitaxel and Docetaxel Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Paclitaxel and Docetaxel Sales Volume by Application: 2019 VS 2023 VS 2030 (Kiloton)
Table 34. Global Paclitaxel and Docetaxel Sales Volume by Application (2019-2024) & (Kiloton)
Table 35. Global Paclitaxel and Docetaxel Sales Volume by Application (2025-2030) & (Kiloton)
Table 36. Global Paclitaxel and Docetaxel Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Paclitaxel and Docetaxel Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Paclitaxel and Docetaxel Price by Application (2019-2024) & (US$/Ton)
Table 39. Global Paclitaxel and Docetaxel Price by Application (2025-2030) & (US$/Ton)
Table 40. Global Paclitaxel and Docetaxel Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Paclitaxel and Docetaxel Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Paclitaxel and Docetaxel Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Paclitaxel and Docetaxel Sales Value by Region (2019-2024) & (%)
Table 44. Global Paclitaxel and Docetaxel Sales Value by Region (2025-2030) & (%)
Table 45. Global Paclitaxel and Docetaxel Sales Volume by Region (Kiloton): 2019 VS 2023 VS 2030
Table 46. Global Paclitaxel and Docetaxel Sales Volume by Region (2019-2024) & (Kiloton)
Table 47. Global Paclitaxel and Docetaxel Sales Volume by Region (2025-2030) & (Kiloton)
Table 48. Global Paclitaxel and Docetaxel Sales Volume by Region (2019-2024) & (%)
Table 49. Global Paclitaxel and Docetaxel Sales Volume by Region (2025-2030) & (%)
Table 50. Global Paclitaxel and Docetaxel Average Price by Region (2019-2024) & (US$/Ton)
Table 51. Global Paclitaxel and Docetaxel Average Price by Region (2025-2030) & (US$/Ton)
Table 52. Key Countries/Regions Paclitaxel and Docetaxel Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Paclitaxel and Docetaxel Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Paclitaxel and Docetaxel Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Paclitaxel and Docetaxel Sales Volume, (2019-2024) & (Kiloton)
Table 56. Key Countries/Regions Paclitaxel and Docetaxel Sales Volume, (2025-2030) & (Kiloton)
Table 57. Phyton Company Information
Table 58. Phyton Introduction and Business Overview
Table 59. Phyton Paclitaxel and Docetaxel Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 60. Phyton Paclitaxel and Docetaxel Product Offerings
Table 61. Phyton Recent Development
Table 62. ScinoPharm Company Information
Table 63. ScinoPharm Introduction and Business Overview
Table 64. ScinoPharm Paclitaxel and Docetaxel Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 65. ScinoPharm Paclitaxel and Docetaxel Product Offerings
Table 66. ScinoPharm Recent Development
Table 67. Novasep Company Information
Table 68. Novasep Introduction and Business Overview
Table 69. Novasep Paclitaxel and Docetaxel Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 70. Novasep Paclitaxel and Docetaxel Product Offerings
Table 71. Novasep Recent Development
Table 72. Samyang Company Information
Table 73. Samyang Introduction and Business Overview
Table 74. Samyang Paclitaxel and Docetaxel Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 75. Samyang Paclitaxel and Docetaxel Product Offerings
Table 76. Samyang Recent Development
Table 77. Polymed Company Information
Table 78. Polymed Introduction and Business Overview
Table 79. Polymed Paclitaxel and Docetaxel Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 80. Polymed Paclitaxel and Docetaxel Product Offerings
Table 81. Polymed Recent Development
Table 82. TAPI (Teva) Company Information
Table 83. TAPI (Teva) Introduction and Business Overview
Table 84. TAPI (Teva) Paclitaxel and Docetaxel Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 85. TAPI (Teva) Paclitaxel and Docetaxel Product Offerings
Table 86. TAPI (Teva) Recent Development
Table 87. Fresenius-kabi Company Information
Table 88. Fresenius-kabi Introduction and Business Overview
Table 89. Fresenius-kabi Paclitaxel and Docetaxel Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 90. Fresenius-kabi Paclitaxel and Docetaxel Product Offerings
Table 91. Fresenius-kabi Recent Development
Table 92. Huiang biopharma Company Information
Table 93. Huiang biopharma Introduction and Business Overview
Table 94. Huiang biopharma Paclitaxel and Docetaxel Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 95. Huiang biopharma Paclitaxel and Docetaxel Product Offerings
Table 96. Huiang biopharma Recent Development
Table 97. Southpharma Company Information
Table 98. Southpharma Introduction and Business Overview
Table 99. Southpharma Paclitaxel and Docetaxel Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 100. Southpharma Paclitaxel and Docetaxel Product Offerings
Table 101. Southpharma Recent Development
Table 102. Yunnan Hande Company Information
Table 103. Yunnan Hande Introduction and Business Overview
Table 104. Yunnan Hande Paclitaxel and Docetaxel Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 105. Yunnan Hande Paclitaxel and Docetaxel Product Offerings
Table 106. Yunnan Hande Recent Development
Table 107. Hainan Yew Pharm Company Information
Table 108. Hainan Yew Pharm Introduction and Business Overview
Table 109. Hainan Yew Pharm Paclitaxel and Docetaxel Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 110. Hainan Yew Pharm Paclitaxel and Docetaxel Product Offerings
Table 111. Hainan Yew Pharm Recent Development
Table 112. Jiangsu Yew Biotechnology Company Information
Table 113. Jiangsu Yew Biotechnology Introduction and Business Overview
Table 114. Jiangsu Yew Biotechnology Paclitaxel and Docetaxel Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 115. Jiangsu Yew Biotechnology Paclitaxel and Docetaxel Product Offerings
Table 116. Jiangsu Yew Biotechnology Recent Development
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Paclitaxel and Docetaxel Downstream Customers
Table 120. Paclitaxel and Docetaxel Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Paclitaxel and Docetaxel Product Picture
Figure 2. Global Paclitaxel and Docetaxel Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Paclitaxel and Docetaxel Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Paclitaxel and Docetaxel Sales Volume (2019-2030) & (Kiloton)
Figure 5. Global Paclitaxel and Docetaxel Sales Price (2019-2030) & (US$/Ton)
Figure 6. Paclitaxel and Docetaxel Report Years Considered
Figure 7. Global Paclitaxel and Docetaxel Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Paclitaxel and Docetaxel Players Sales Volume Ranking (2023) & (Kiloton)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Paclitaxel and Docetaxel Revenue in 2023
Figure 10. Paclitaxel and Docetaxel Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Paclitaxel Picture
Figure 12. Docetaxel Picture
Figure 13. Global Paclitaxel and Docetaxel Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Paclitaxel and Docetaxel Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Paclitaxel and Docetaxel Sales Volume by Type (2019 VS 2023 VS 2030) & (Kiloton)
Figure 16. Global Paclitaxel and Docetaxel Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Paclitaxel and Docetaxel Price by Type (2019-2030) & (US$/Ton)
Figure 18. Product Picture of Ovarian Cancer
Figure 19. Product Picture of Cervical Cancer
Figure 20. Product Picture of Breast Cancer
Figure 21. Product Picture of Others
Figure 22. Global Paclitaxel and Docetaxel Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Paclitaxel and Docetaxel Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Paclitaxel and Docetaxel Sales Volume by Application (2019 VS 2023 VS 2030) & (Kiloton)
Figure 25. Global Paclitaxel and Docetaxel Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Paclitaxel and Docetaxel Price by Application (2019-2030) & (US$/Ton)
Figure 27. North America Paclitaxel and Docetaxel Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Paclitaxel and Docetaxel Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Paclitaxel and Docetaxel Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Paclitaxel and Docetaxel Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Paclitaxel and Docetaxel Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Paclitaxel and Docetaxel Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Paclitaxel and Docetaxel Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Paclitaxel and Docetaxel Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Paclitaxel and Docetaxel Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Paclitaxel and Docetaxel Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Paclitaxel and Docetaxel Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Paclitaxel and Docetaxel Sales Volume (%), (2019-2030)
Figure 39. United States Paclitaxel and Docetaxel Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Paclitaxel and Docetaxel Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Paclitaxel and Docetaxel Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Paclitaxel and Docetaxel Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Paclitaxel and Docetaxel Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Paclitaxel and Docetaxel Sales Value by Application (%), 2023 VS 2030
Figure 45. China Paclitaxel and Docetaxel Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Paclitaxel and Docetaxel Sales Value by Type (%), 2023 VS 2030
Figure 47. China Paclitaxel and Docetaxel Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Paclitaxel and Docetaxel Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Paclitaxel and Docetaxel Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Paclitaxel and Docetaxel Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Paclitaxel and Docetaxel Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Paclitaxel and Docetaxel Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Paclitaxel and Docetaxel Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Paclitaxel and Docetaxel Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Paclitaxel and Docetaxel Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Paclitaxel and Docetaxel Sales Value by Application (%), 2023 VS 2030
Figure 57. India Paclitaxel and Docetaxel Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Paclitaxel and Docetaxel Sales Value by Type (%), 2023 VS 2030
Figure 59. India Paclitaxel and Docetaxel Sales Value by Application (%), 2023 VS 2030
Figure 60. Paclitaxel and Docetaxel Industrial Chain
Figure 61. Paclitaxel and Docetaxel Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
